Prognostic factors in progressive high-grade glial tumors treated with systemic approach: A single center experience


Alan O., AKIN TELLİ T., BAŞOĞLU TÜYLÜ T., Arikan R., DEMİRCAN N. C., Ercelep O., ...Daha Fazla

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, cilt.27, sa.2, ss.329-339, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 27 Sayı: 2
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1177/1078155220920684
  • Dergi Adı: JOURNAL OF ONCOLOGY PHARMACY PRACTICE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Agricultural & Environmental Science Database, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE
  • Sayfa Sayıları: ss.329-339
  • Anahtar Kelimeler: High-grade gliomas, glioblastoma multiforme, ATRX status, IDH status, thrombosis, BEVACIZUMAB-INDUCED HYPERTENSION, CENTRAL-NERVOUS-SYSTEM, VENOUS THROMBOEMBOLISM, ADJUVANT TEMOZOLOMIDE, GLIOBLASTOMA, ATRX, MUTATIONS, SURVIVAL, GLIOMA, IDH1
  • Marmara Üniversitesi Adresli: Evet

Özet

Purpose